Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy
- 1 August 2018
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 40, 1-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Scalp Hypothermia for Preventing Alopecia During Chemotherapy. A Systematic Review and Meta-Analysis of Randomized Controlled TrialsClinical Breast Cancer, 2018
- Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysisBreast Cancer Research and Treatment, 2017
- The Role of Hair Loss in Cancer IdentityCancer Nursing, 2017
- Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast CancerJAMA, 2017
- Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast CancerJAMA, 2017
- Efficacy of interventions for prevention of chemotherapy‐induced alopecia: A systematic review and meta‐analysisInternational Journal of Cancer, 2014
- Factors Influencing the Effectiveness of Scalp Cooling in the Prevention of Chemotherapy-Induced AlopeciaThe Oncologist, 2013
- Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - Results of the Dutch Scalp Cooling RegistryActa Oncologica, 2012
- Classification of the types of androgenetic alopecia (common baldness) occurring in the female sexBritish Journal of Dermatology, 1977